Conference · London, United Kingdom
EASL-AASLD joint meeting on alcoholic liver disease and alcoholic hepatitis
Pharmaceuticals
Key numbers
- Editions on record
- 1first in 2017
About EASL-AASLD joint meeting on alcoholic liver disease and alcoholic hepatitis
During the EASL-AASLD joint meeting on "Definition, therapeutic advances and clinical endpoints in alcoholic liver disease and alcoholic hepatitis" topics on public health, diagnostic definitions, therapeutic advances and clinical endpoints in alcohol related liver disease and alcoholic hepatitis will be discussed. Alcohol related liver disease (ALD) is the most prevalent cause of advanced liver disease and liver related mortality in Western countries. Research in ALD spans a wide spectrum from public health to basic science and despite being the ‘Cinderella’ disease area in hepatology, there have been a number of advances in recent years. We would like to take this opportunity to review with you the emerging data from clinical, translational and basic science studies in ALD. The organisers: Prof. Philippe Mathurin, Prof. Vijay Shah, Prof. Gyongyi Szabo and Prof. Mark Thursz Website: https://go.evvnt.com/112487-1
From our listing of this edition. Details may have changed since.
Editions
| Year | Dates | Where | Exhibitors | Visitors |
|---|---|---|---|---|
| 2017 | 30 Sep – 1 Oct 2017 | Pullman London St Pancras London, United Kingdom | — | — |
Past editions from the bvents archive (2008–2019) and organiser figures where they were published.
Questions
When is EASL-AASLD joint meeting on alcoholic liver disease and alcoholic hepatitis?
The next dates haven't been confirmed. The last edition we have on record was 30 Sep – 1 Oct 2017.
Where is it held?
The last edition we have was at Pullman London St Pancras, London, United Kingdom.